Mucolytic enzyme systems; inhibition of hyaluronidase by serum in infectious diseases.

Mucolytic enzyme systems; inhibition of hyaluronidase by serum in infectious diseases. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Mucolytic enzyme systems; inhibition of hyaluronidase by serum in infectious diseases. Abstract Text:

M L GRAIS,D GLICK,

Mucolytic enzyme systems; inhibition of hyaluronidase by serum in infectious diseases.

Mucolytic enzyme systems; inhibition of hyaluronidase by serum in infectious diseases. Publishing Authors By Initials

ML GRAIS,D GLICK,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Mucolytic enzyme systems; inhibition of hyaluronidase by serum in infectious diseases. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Journal of infectious diseases

VOLUME: 85

Page Numbers: 101-6

Journal Abbreviation: J. Infect. Dis.

ISSN: 0022-1899

DAY: 27

MONTH: 12

YEAR: 2007

Mucolytic enzyme systems; inhibition of hyaluronidase by serum in infectious diseases. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 413675

Mucolytic enzyme systems; inhibition of hyaluronidase by serum in infectious diseases. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Mucolytic enzyme systems; inhibition of hyaluronidase by serum in infectious diseases. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Mucolytic enzyme systems; inhibition of hyaluronidase by serum in infectious diseases.

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Infect Dis

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Mucolytic enzyme systems; inhibition of hyaluronidase by serum in infectious diseases Related Publications

• 1-Aminocyclopropane-1-carboxylate deaminase from Pseudomonas putida UW4 facilitates the growth of canola in the presence of salt.
• Adjuvant therapy of primary breast cancer. Closing summary and outlook.
• Breast CT.
• Causation: a loosely founded concept in epidemiology.
• Clinical trials and external validity.
• Closing in on the Puzzle of ONJ.
• Comorbidities in older patients with HIV: a retrospective study.
• Double-contrast barium enema for colorectal cancer screening: a review of the issues and a comparison with other screening alternatives.
• Effect of somatic mutation on DNA binding properties of anti-DNA autoantibodies.
• Ethical considerations in publishing research involving human subjects.
• Expression profile of skin papillomas with high cancer risk displays a unique genetic signature that clusters with squamous cell carcinomas and predicts risk for malignant conversion.
• Flexible 3D pharmacophores as descriptors of dynamic biological space.
• Fluorescence microscopy and thin-section electron microscopy.
• Focus your leadership. Preparing for a major incident response.
• Immigration and living arrangements: moving beyond economic need versus acculturation.
• Inhibition of the mitochondrial F1F0-ATPase by ligands of the peripheral benzodiazepine receptor.
• Marañón, intersexuality and the biological construction of gender in 1920s Spain.
• Measles outbreak in a Vancouver school population: relative risk and vaccine efficacy.
• Mechanistic basis for therapeutic targeting of the mitochondrial F1F0-ATPase.
• Metabolic impact of switching antipsychotic therapy to aripiprazole after weight gain: a pilot study.
• Mucolytic enzyme systems; effects of tissue extracts and body fluids, certain steroids, and hemoglobin derivatives on hyaluronidase activity.
• Mucolytic enzyme systems; inhibition of hyaluronidase by human blood serum during the normal menstrual cycle and pregnancy.
• Mucolytic enzyme systems; inhibition of hyaluronidase by serum in human cancer.
• Mucolytic enzyme systems; inhibition of hyaluronidase by serum in infectious diseases.
• Oncology in transition: the pivotal role of the American Society of Clinical Oncology.
• Poverty and human development: a challenge for us all.
• Risky liaisons: what is the relationship between oral conditions and nonoral diseases?
• Role of conformational dynamics in sequence-specific autoantibody*ssDNA recognition.
• Smooth handoffs. How to put the team focus back into ALS/BLS interactions.
• Structural modeling of sequence specificity by an autoantibody against single-stranded DNA.